The herpes simplex virus type 1 infected cell protein 22

Area of Science:

• Virology
• Molecular Biology
• Cellular Regulation

Background:

• Herpes simplex virus type 1 (HSV-1) immediate-early (IE) protein ICP22 is a nuclear viral regulator.
• ICP22's function is essential in some cell types and animal models but not universally required.
• ICP22 undergoes extensive phosphorylation and nucleotidylylation by viral and cellular kinases.

Purpose of the Study:

• To elucidate the multifaceted role of ICP22 in regulating HSV-1 gene expression.
• To investigate the mechanisms by which ICP22 influences viral and cellular kinase pathways.
• To understand ICP22's contribution to the activation of viral DNA replication and gene transcription.

Main Methods:

• Analysis of ICP22's interactions with viral and cellular kinases, including UL13 and cdk9.
• Investigation of ICP22's role in the phosphorylation of RNA polymerase II.
• Examination of ICP22's involvement in the activation of cdc2 and regulation of cyclins.
• Assessment of the ICP22-dependent modification of topoisomerase IIα.

Main Results:

• ICP22 is crucial for efficient expression of HSV-1 early (E) and some late (L) genes.
• ICP22, with UL13 kinase, phosphorylates RNA polymerase II and activates cdc2.
• ICP22 facilitates the degradation of cyclins A and B and the formation of the cdc2-UL42 complex.
• The cdc2-UL42 complex, guided by ICP22, modifies topoisomerase IIα, promoting L gene expression.

Conclusions:

• ICP22 is a key regulator of HSV-1 gene expression, impacting both viral and cellular processes.
• ICP22 orchestrates a cascade of events involving kinase activation, protein modification, and complex formation.
• ICP22's interactions are critical for efficient viral replication and the transition from early to late gene expression.